Şahin Bedir

Articles published in international peer-reviewed journals

A1. Bedir, Ş., Alkan Şen, G., Abbasov, H., Guliyev, M., Sünger, E., Çakan Demirel, B., Şengül, N., Oyman, A., Bozkaya, Y., Bilici, A., Turna, H., Özgüroğlu, M., & Erdem, GU (2026). Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy. Biomedicines , 14 (8), 1825. https://doi.org/10.3390/biomedicines14081825

A2. Bedir, Ş., Kapağan, T., Bozkaya, Y., Oyman, A., Fidan, MC, Guliyev, M., Abbasov, H., Demirci, NS, Yıldırım Doğan, HG, Çelik, E., Bulut, N., & Erdem, GU (2026). Prognostic Impact of the Lung Immune Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers , 18 (7), 1170. https://doi.org/10.3390/cancers18071170

A3. Bedir, Ş., Yeşilova, UA, Tokoçin, M., Çakan Demirel, B., Bozkaya, Y., Oyman, A., Guliyev, M., Abbasov, H., Demirci, NS, Değerli, E., Usul, G., Şen, E., Bulut, N., & Erdem, GU (2026). Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy. Medicina , 62 (1), 200. https://doi.org/10.3390/medicina62010200

A4. Bedir, Ş., Kapagan, T., Çakan Demirel, B., Tokocin, M., Yıldırım, Ç., Taş, S., Bozkaya, Y., Oyman, A., Bulut, N., & Erdem, GU (2026). Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Journal of Clinical Medicine , 15 (5), 1898. https://doi.org/10.3390/jcm15051898

A5 . Sengul Samanci N, Cikman DI, Oruc K, Bedir S, Çelik E, Degerli E, Derin S, Demirelli FH, Özgüroğlu M. Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer. Tumors. 2021 Aug;107(4):304-310. doi: 10.1177/0300891620953468. Epub 2020 Sep 16. PMID: 32935638.

A6. Sengul Samanci N, Çelik E, Bagcilar O, Erol BC, Bicki E, Oruc K, Bedir S, Degerli E, Derin S, Demirci NS, Demirelli FH. Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma. Melanoma Res. 2020 Oct;30(5):477-483. doi: 10.1097/CMR.0000000000000678. PMID: 32898388.

A7. Celik E, Samanci NS, Karadag M, Demirci NS, Cikman DI, Derin S, Bedir S, Degerli E, Oruc K, Oztas NS, Demirelli FH. Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency. J Oncol Pharm Pract. 2021 Oct;27(7):1665-1673. doi: 10.1177/1078155220964895. Epub 2020 Oct 12. PMID: 33040673.

A8. Değerli E, Şentürk Öztaş N, Alkan G, Bedir Ş, Derin S, Valıkhanova N, Saraç B, Kacar E, Demirci NS, Demirelli HF, Turna H. Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy. JChemother. 2023 Feb;35(1):29-38. doi:10.1080/1120009X.2022.2043514. Epub 2022 Feb 26. PMID: 35220928.

A9. Değerli E, Derin S, Oruç K, Şengül Samancı N, Bedir Ş, Çelik E, Şentürk Öztaş N, Alkan G, Demirelli FH, Demirci NS. The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience. J Med Virol. 2021 Oct;93(10):5839-5845. doi: 10.1002/jmv.27123. Epub 2021 Jun 12. PMID: 34081337; PMCID: PMC8242719.

A10. Değerli E, Oruç K, Şentürk Öztaş N, Alkan Şen G, Bedir Ş, Demirci NS, Demirelli HF. Prognostic factors in Kaposi sarcoma, single centre experience. Australas J Dermatol. 2024 Aug;65(5):444-450. doi: 10.1111/ajd.14309. Epub 2024 May 17. PMID: 38760927.

National/international books written or chapters in books:

Chapters in national/international books:

Tumor Agnostic Treatment in Non-Small Cell Lung Cancer

Tumor Agnostic Treatment in Non-Small Cell Lung Cancer

Bedir Ş. Tumor-agnostic treatment in non-small cell lung cancer. Akıncı MB, editor. Lung Cancer. 1st Edition. Ankara: Türkiye Klinikleri; 2024. p.52-7.

Articles published in national peer-reviewed journals:

D1 . BEDİR Ş, ERDOĞAN M, ÖZDEMİR M, YÜREKLİ BS, ERTAN Y, MAKAY Ö. Are Autoimmune Thyroid Diseases a Risk Factor for Thyroid Cancers?. Namik Kemal Med J. 2023 Jun;11(2):111-117. doi:10.4274/nkmj.galenos.2023.36025.

D2 Bedir, Şahin, Samancı, N. Şengül, Çelik, E., Oruç, K., Değerli, E., Derin, S., … Demirelli, FH (2025). Clinical Analysis of Multiple Primary Malignant Tumors: A Single-Center Experience. Cerrahpaşa Medical Journal , 49 , 1–5. https://doi.org/10.5152/cjm.2025.25022

D3 Celik E, Samanci NS, Derin S, Bedir S, Degerli E, Oruc K, Oztas NS, Alkan G, Senyigit A, Turna ZH. A single center’s experience of the extrapulmonary neuroendocrine carcinomas. North Clin Istanb. 2021 Feb 14;9(1):35-40. doi: 10.14744/nci.2021.47887. PMID: 35340315; PMCID: PMC8889205.

D4 Sengul, N., Bedir, S., Celik, E., Icli, TB, Kavla, Y., Turan, S., … & Demirelli, FH (2024). Levels of Anxiety and Depression in Patients with Cancer During the COVID-19 Pandemic.  Eurasian Journal of Medical Investigation ,  8 (2).

D5. Şengül Samancı N, Celik E, Degerli E, Kasap M, Oruc K, Bedir S, Derin S, Senturk N, Poyraz B, Turna Z, Demirelli F. FACTORS OF AFFECTING SLEEP QUALITY IN CANCER PATIENTS. NKMJ. August 2020;8(2):138-144. doi:10.37696/nkmj.674879

Papers presented at national scientific meetings and published in proceedings:

E1.S -073 Clinicopathology Risk Factors in Triple Negative Breast Cancer Patients Undergoing Neoadjuvant Therapy, Eurasian Interdisciplinary Oncology Congress, October 2-6, 2024, Bafra, TRNC

Other publications:

G1 . Sengul Samanci N, Yılmaz U, Bedir S, Ozgur Yurttas N, Oruc K, Durak Sahin Z, Celik E, Toplutas KN, Akı H, Eskazan AE, Demirelli FH. Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation. J Oncol Pharm Pract. 2020 Dec;26(8):2042-2046. doi: 10.1177/1078155220918627. Epub 2020 Apr 16. PMID: 32299317.

G2 Değerli E, Alkan G, Öztaş NŞ, Bedir Ş, Derin S, Demirci NS. Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme. J Oncol Pharm Pract. 2022 Apr;28(3):746-749. doi: 10.1177/10781552211066888. Epub 2021 Dec 8. PMID: 34878367.

G3 Gokalp C, Cetin C, Bedir S, Duman S. Gitelman syndrome presenting with cerebellar ataxia: a case report. Acta Neurol Belg. 2020 Apr;120(2):443-445. doi: 10.1007/s13760-019-01095-6. Epub 2019 Feb 12. PMID: 30756313.